Cargando…

MON-231 Dietary Interventions Can Ameliorate Polycystic Ovary Syndrome (PCOS) Traits in a PCOS Mouse Model

Polycystic ovary syndrome (PCOS) is a complex, heterogeneous disorder characterized by reproductive, endocrine and metabolic abnormalities; however, its aetiology is unknown and current medical management relies solely on symptomatic treatment. Hyperandrogenism is a defining characteristic of PCOS,...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodriguez Paris, Valentina, Solon-Biet, Samantha, Edwards, Melissa, Cox, Madeleine, Ledger, William, Gilchrist, Robert, Simpson, Stephen, Handelsman, David, Walters, Kirsty
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550886/
http://dx.doi.org/10.1210/js.2019-MON-231
_version_ 1783424285578100736
author Rodriguez Paris, Valentina
Solon-Biet, Samantha
Edwards, Melissa
Cox, Madeleine
Ledger, William
Gilchrist, Robert
Simpson, Stephen
Handelsman, David
Walters, Kirsty
author_facet Rodriguez Paris, Valentina
Solon-Biet, Samantha
Edwards, Melissa
Cox, Madeleine
Ledger, William
Gilchrist, Robert
Simpson, Stephen
Handelsman, David
Walters, Kirsty
author_sort Rodriguez Paris, Valentina
collection PubMed
description Polycystic ovary syndrome (PCOS) is a complex, heterogeneous disorder characterized by reproductive, endocrine and metabolic abnormalities; however, its aetiology is unknown and current medical management relies solely on symptomatic treatment. Hyperandrogenism is a defining characteristic of PCOS, and diet is inherently associated since obesity is present in 40-80% of PCOS women. Dietary interventions are appealing as a powerful public health intervention to prevent or ameliorate the manifestation of PCOS, but the optimal diet for PCOS treatment remains unclear. Previously we proved in female mice that reproductive and metabolic traits contributing to the PCOS phenotype are strongly impacted by dietary macronutrient balance. Therefore, to determine the impact of dietary macronutrient balance on the development of PCOS, we provided our experimental mouse model of dihydrotestosterone (DHT)-induced PCOS and control mice with ad libitum access to one of 10 diets varying in protein (P), carbohydrate (C) and fat (F) content. All control mice cycled. Most PCOS mice exhibited complete estrous acyclicity, but despite the presence of hyperandrogenism, cyclicity was restored in PCOS mice consuming a C intake between 20-30kJ/day. Correspondingly, ovaries collected from PCOS mice with diet-restored cyclicity exhibited corpora lutea, confirming ovulations. As with cyclicity, ovulation dysfunction was ameliorated when PCOS mice consumed a C intake between 20-30kJ/day (P<0.05). Interestingly, PCOS mice that cycled were not the leanest PCOS females, displaying a higher average body weight (24.4g +/- 0.2) compared to controls (21.7g +/- 0.2; P<0.001). However, PCOS mice were able to maintain a body weight comparable to controls by reducing C intake to <20kJ/day (P<0.001). PCOS is associated with higher levels of circulating cholesterol, and regardless of diet, PCOS mice overall displayed a significant increase in cholesterol levels (61.5mg/dL +/- 2.7; P<0.05) compared to controls (53.1mg/dL +/- 2.2). This feature was aggravated by increasing F consumption (P<0.001), but decreased to control levels by reducing F intake to <20kJ/day (P<0.001). These findings provide evidence that PCOS traits can be ameliorated through dietary interventions to restore reproductive and metabolic abnormalities to control levels, although it appears that these hallmark PCOS traits are differentially sensitive to dietary macronutrient balance.
format Online
Article
Text
id pubmed-6550886
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Endocrine Society
record_format MEDLINE/PubMed
spelling pubmed-65508862019-06-13 MON-231 Dietary Interventions Can Ameliorate Polycystic Ovary Syndrome (PCOS) Traits in a PCOS Mouse Model Rodriguez Paris, Valentina Solon-Biet, Samantha Edwards, Melissa Cox, Madeleine Ledger, William Gilchrist, Robert Simpson, Stephen Handelsman, David Walters, Kirsty J Endocr Soc Reproductive Endocrinology Polycystic ovary syndrome (PCOS) is a complex, heterogeneous disorder characterized by reproductive, endocrine and metabolic abnormalities; however, its aetiology is unknown and current medical management relies solely on symptomatic treatment. Hyperandrogenism is a defining characteristic of PCOS, and diet is inherently associated since obesity is present in 40-80% of PCOS women. Dietary interventions are appealing as a powerful public health intervention to prevent or ameliorate the manifestation of PCOS, but the optimal diet for PCOS treatment remains unclear. Previously we proved in female mice that reproductive and metabolic traits contributing to the PCOS phenotype are strongly impacted by dietary macronutrient balance. Therefore, to determine the impact of dietary macronutrient balance on the development of PCOS, we provided our experimental mouse model of dihydrotestosterone (DHT)-induced PCOS and control mice with ad libitum access to one of 10 diets varying in protein (P), carbohydrate (C) and fat (F) content. All control mice cycled. Most PCOS mice exhibited complete estrous acyclicity, but despite the presence of hyperandrogenism, cyclicity was restored in PCOS mice consuming a C intake between 20-30kJ/day. Correspondingly, ovaries collected from PCOS mice with diet-restored cyclicity exhibited corpora lutea, confirming ovulations. As with cyclicity, ovulation dysfunction was ameliorated when PCOS mice consumed a C intake between 20-30kJ/day (P<0.05). Interestingly, PCOS mice that cycled were not the leanest PCOS females, displaying a higher average body weight (24.4g +/- 0.2) compared to controls (21.7g +/- 0.2; P<0.001). However, PCOS mice were able to maintain a body weight comparable to controls by reducing C intake to <20kJ/day (P<0.001). PCOS is associated with higher levels of circulating cholesterol, and regardless of diet, PCOS mice overall displayed a significant increase in cholesterol levels (61.5mg/dL +/- 2.7; P<0.05) compared to controls (53.1mg/dL +/- 2.2). This feature was aggravated by increasing F consumption (P<0.001), but decreased to control levels by reducing F intake to <20kJ/day (P<0.001). These findings provide evidence that PCOS traits can be ameliorated through dietary interventions to restore reproductive and metabolic abnormalities to control levels, although it appears that these hallmark PCOS traits are differentially sensitive to dietary macronutrient balance. Endocrine Society 2019-04-30 /pmc/articles/PMC6550886/ http://dx.doi.org/10.1210/js.2019-MON-231 Text en Copyright © 2019 Endocrine Society https://creativecommons.org/licenses/by-nc-nd/4.0/ This article has been published under the terms of the Creative Commons Attribution Non-Commercial, No-Derivatives License (CC BY-NC-ND; https://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Reproductive Endocrinology
Rodriguez Paris, Valentina
Solon-Biet, Samantha
Edwards, Melissa
Cox, Madeleine
Ledger, William
Gilchrist, Robert
Simpson, Stephen
Handelsman, David
Walters, Kirsty
MON-231 Dietary Interventions Can Ameliorate Polycystic Ovary Syndrome (PCOS) Traits in a PCOS Mouse Model
title MON-231 Dietary Interventions Can Ameliorate Polycystic Ovary Syndrome (PCOS) Traits in a PCOS Mouse Model
title_full MON-231 Dietary Interventions Can Ameliorate Polycystic Ovary Syndrome (PCOS) Traits in a PCOS Mouse Model
title_fullStr MON-231 Dietary Interventions Can Ameliorate Polycystic Ovary Syndrome (PCOS) Traits in a PCOS Mouse Model
title_full_unstemmed MON-231 Dietary Interventions Can Ameliorate Polycystic Ovary Syndrome (PCOS) Traits in a PCOS Mouse Model
title_short MON-231 Dietary Interventions Can Ameliorate Polycystic Ovary Syndrome (PCOS) Traits in a PCOS Mouse Model
title_sort mon-231 dietary interventions can ameliorate polycystic ovary syndrome (pcos) traits in a pcos mouse model
topic Reproductive Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550886/
http://dx.doi.org/10.1210/js.2019-MON-231
work_keys_str_mv AT rodriguezparisvalentina mon231dietaryinterventionscanamelioratepolycysticovarysyndromepcostraitsinapcosmousemodel
AT solonbietsamantha mon231dietaryinterventionscanamelioratepolycysticovarysyndromepcostraitsinapcosmousemodel
AT edwardsmelissa mon231dietaryinterventionscanamelioratepolycysticovarysyndromepcostraitsinapcosmousemodel
AT coxmadeleine mon231dietaryinterventionscanamelioratepolycysticovarysyndromepcostraitsinapcosmousemodel
AT ledgerwilliam mon231dietaryinterventionscanamelioratepolycysticovarysyndromepcostraitsinapcosmousemodel
AT gilchristrobert mon231dietaryinterventionscanamelioratepolycysticovarysyndromepcostraitsinapcosmousemodel
AT simpsonstephen mon231dietaryinterventionscanamelioratepolycysticovarysyndromepcostraitsinapcosmousemodel
AT handelsmandavid mon231dietaryinterventionscanamelioratepolycysticovarysyndromepcostraitsinapcosmousemodel
AT walterskirsty mon231dietaryinterventionscanamelioratepolycysticovarysyndromepcostraitsinapcosmousemodel